Fortis Hospitals Mumbai Launches Citywide Campaign for Brain Health Awareness on World Brain Day
Fortis Mumbais Helmet Pehna Kya sqad all set to engage Mumbaikars on World Brain Day 2025
Volunteers wearing helmets attracted attention and struck up conversations everywhere from local trains and flower markets to office parks and roadside food stands, leading Mumbaikars to wonder, 'Why are they wearing the helmet here'The answer To emphasize a crucial point: your brain should be protected every day, not only in the event of an accident. Fortis Hospitals Mumbai questioned common belief that brain safety is solely related to accident-related trauma by introducing a symbol of physical protection (the helmet) in routine, low or no-risk situations. Instead, the campaign reframed helmets as a symbol of routine checkups, mental wellness, early detection, and lifestyle modification. The initiative aims to remind people that brain health is a daily priority rather than an emergency, this innovative activation not only attracted Mumbaikars attention but also struck the relevant conversations.
This initiative couldn't be timed better. Across India, neurological disorders are becoming an everyday reality for more and more families. Over the past three decades, cases of conditions like Stroke, Epilepsy, Migraine, and Dementia have more than doubled. Today, these account for almost 10% of the nation's overall disease burden; Stroke alone took the lives of nearly 7 lakh people in 2019. What's alarming is that stressors we live with daily: high blood pressure, poor diet choices, rising pollution levels, and chronic mental strain are the triggers. A comprehensive study led by the India State-Level Disease Burden Initiative-supported by ICMR, PHFI, IHME, and the Ministry of Health-highlighted these trends and published the findings in The Lancet Global Health. It is wake-up call, our brain health is far more fragile than we realise. That's what makes the Fortis Mumbai campaign so meaningful. By turning helmet into a powerful symbol, and carries a message that's hard to miss: protecting your brain is not just about reacting to emergencies; it's about living more mindfully, every single day.
Talking about the initiative, Dr S Narayani, Business Head – Fortis Hospitals, Maharashtra, said, 'At Fortis, our mission goes beyond treating illness, we aim to prevent it through education and awareness. The helmet is a powerful choice for the campaign as it reminds us that just as we protect our head from injury on the roads, we must also protect our brain through awareness, timely action, and healthy choices. For us preventative healthcare is the foundation of a healthy society and through this campaign, we hope to engage the community, and empower them to take proactive steps towards better brain health.'
As part of World Brain Day, Fortis Hospitals in Mumbai brought brain health awareness to the forefront with a unique, people-first approach. At all four units-Mulund, Kalyan, Vashi, and Mahim-Patient Care Services staff wore helmets within hospital premises, sparking heartfelt conversations with patients and their families about the importance of brain health. Community sessions hosted at open spaces helped Neurologists share insights on recognizing early warning signs, and stressed the value of timely care. The initiative extended to notable locations across Mumbai, as reactions and real-time moments were shared across Fortis Mumbai's social media pages, helping the message of brain health reach the community at large.
'When it comes to brain health, lifestyle plays a very important role and should not be overlooked. One particular acronym that tell my patients to lookout for is termed SHAAADOWSSS, which stands for Smoking, Hypertension, Age over 60 years, Alcohol Abuse, Atrial fibrillation, Diabetes, Obesity, Wellspring (family history), Stress, Sedentary Lifestyle and Sleep Disorders. True to its name, these conditions follow you around like a shadow and if left unmanaged they significantly increase your risk of developing issues like Stroke. The good news is simple, conscious changes in your daily routine can drastically lower that risk and protect your brain for the long run,' said Dr Ashok Hande, Director – NeuroSurgery, Fortis Hiranandani Hospital, Vashi, while talking about the role lifestyle awareness plays in brain health preservation.
Dr Sreelakshmi N. Consultant-Neurology, S.L. Raheja Hospital, Mahim, said, 'Everything you experience flows from the brain. Yet, your brain remains the body's most sensitive organs. Issues like Stroke can appear suddenly, while conditions such as Dementia may develop gradually and quietly. That's why paying attention to even subtle changes matters. Don't ignore the signs your body may be giving you. Acting early can change outcomes.'
Highlighting the role family history, Dr Gurneet Singh Sawhney, Director-Stereotaxy and Functional Neurosciences, Fortis Hospital, Mulund said, 'Family history plays a crucial role when managing disease burden. If someone in the patient's family has had ailments like Dementia, Stroke etc. then one's chances of developing neurological complications may be higher. That makes it even more critical to be aware of the warning signs, get regular health check-ups, and adopt a healthy lifestyle to reduce your risk.'
DrRushabh Chheda, Consultant, Neurosurgery and Stroke Intervention Specialist, Fortis Hospital Kalyan, said, 'Brain health is too important to take chances with. Any warning sign you observe should be taken as a medical emergency, not be considered a wait-and-watch situation. There is a common saying in Neurology which says – time is brain – thus the quicker you act, the more brain function can be saved and every minute counts when it comes to protecting your brain and your life, so act fast to preserve what matters most.'
The message is clear: it's time for Mumbai to act decisively with stronger strategies for prevention, better awareness, and more accessible neurological care-before this silent epidemic grows louder.
About Fortis Healthcare
Fortis Healthcare Limited – an IHH Healthcare Berhad Company – is a leading integrated healthcare services provider in India. It is one of the largest healthcare organizations in the country with 27 healthcare facilities, ~4,750 operational beds (including O&M facilities), and over 400 diagnostics centers (including JVs). The Company is listed on the BSE Ltd and National Stock Exchange (NSE) of India. It draws strength from its partnership with a global major and parent company – IHH, to build upon its culture of world-class patient care and superlative clinical excellence. Fortis employs over 23,000 people (including Agilus Diagnostics Limited) who share its vision of becoming the world's most trusted healthcare network. Fortis offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
41 minutes ago
- The Hindu
Brain tumours: when a headache, memory lapse, or seizure deserves a second look
Every year, over 40,000 individuals in India are diagnosed with brain tumours, according to data from the Indian Council of Medical Research (ICMR). Yet, in many cases, the diagnosis comes too late. The early warning signs—often subtle, fleeting, or mistaken for everyday stress—are overlooked until symptoms become severe. Following the observance of World Brain Day on July 22 , it is vital to recognise that timely diagnosis and multidisciplinary care can make a significant difference in not only survival, but also in long-term recovery and quality of life for patients and their families. When the body whispers Brain tumours are complex. They vary in type, location, and behaviour—and so do their symptoms. In clinical practice, I often see patients who, in hindsight, experienced signs long before their diagnosis. These early symptoms are frequently dismissed as benign issues: a tension headache, forgetfulness, vision strain, or clumsiness. Common symptoms of brain tumours include: Persistent or worsening headaches Memory lapses or personality changes Difficulty in speaking or finding words Blurred or double vision New-onset seizures Trouble with balance or coordination It is important to understand that many of these symptoms—particularly headaches, giddiness, or occasional forgetfulness—are very common and more often than not due to benign conditions like migraines, tension headaches, or positional vertigo. Not every headache warrants a brain scan. However, when these symptoms are unusual in pattern, progressively worsening, or accompanied by other neurological signs, a medical evaluation is essential. The key challenge is that these symptoms can appear mild or sporadic, leading to delays in seeking medical attention. But when the brain is affected—even subtly—it often tries to signal distress. We need to listen more closely. Children are not immune One of the most overlooked realities is that brain tumours affect children too. Among paediatric populations, tumours in the cerebellum—such as medulloblastoma—are relatively common. The signs, however, may not always be easy to spot. In children, red flags include: Headaches, especially in the morning Repeated vomiting without a clear cause Unsteady gait or difficulty walking Clumsiness or frequent falls Unlike adults, children may not articulate their discomfort clearly. A parent's intuition, in such cases, becomes crucial. Prompt neurological evaluation can lead to early diagnosis and treatment, which significantly improves outcomes. With timely surgery, radiation, chemotherapy, and structured rehabilitation, many children not only survive but go on to live full, healthy adult lives. The ripple effects of a brain tumour The impact of a brain tumour extends far beyond the individual. It disrupts family dynamics, imposes financial burdens, and creates emotional strain for caregivers. It can affect workplace productivity and community engagement. That is why recovery must be viewed not just through a medical lens but a social one. When treated early, many patients return to school, work, and community life. The difference lies in how quickly the tumour is recognised and how comprehensively it is managed. The power of modern tools and teamwork Neuro-oncology teams use a suite of advanced tools designed to enhance precision and safety: neuronavigation systems function like GPS during surgery, guiding the surgeon with remarkable accuracy. High-resolution operating microscopes allow us to see deep brain structures clearly. Awake craniotomy enables patients to stay awake during surgery to protect speech and movement centres. Intraoperative neurophysiological monitoring helps preserve critical brain functions during complex procedures. Comprehensive post-operative rehabilitation ensures that recovery continues well beyond the operating room. These innovations help us safely access delicate regions of the brain while preserving the patient's independence and cognitive function. A realistic, hopeful outlook While early detection improves prognosis, it is important to acknowledge that not all brain tumours behave predictably. Some aggressive tumours may resist treatment even when diagnosed early. Others may lie dormant and symptom-free for extended periods. That said, the opportunity for meaningful intervention exists at nearly every stage. Whether through surgical removal, chemotherapy, radiation, or supportive therapies, modern neuro-oncology offers real hope—particularly when treatment is tailored to the individual. Brain tumours don't always present dramatically. They may arrive disguised as a persistent headache, an uncharacteristic lapse in memory, or a subtle speech difficulty. In children, they may be hidden behind a morning vomit or a minor fall. These are not signs to ignore. This World Brain Day, let us renew our commitment to awareness and early action. By paying attention to the whispers, we can catch the signs sooner, act faster, and improve the lives of those affected. Because sometimes, listening to the smallest signals leads to the biggest differences. (Dr. Komal Prasad C. is a senior consultant – neurosurgery, Narayana Health City, Bengaluru. drkomalprasad@
The Hindu
20 hours ago
- The Hindu
ICMR study finds only 28.5% of cancer patients receive radiotherapy in India
Radiotherapy is a cornerstone of cancer treatment in India, yet its expansion is hindered by high investment costs and effective planning, target estimation based on cancer burden are crucial to meet the radiotherapy demands of patients with cancer, noted a recent Indian Council for Medical Research (ICMR) study published in the UK-based BioMed Central (BMC) cancer journal early this month. Major shortfall in radiotherapy access India is faced with a substantial shortfall in radiotherapy utilisation across all cancer types and 28.5 percent of cancer patients receive radiotherapy, which is lower than the estimated optimal rate of 58.4 per cent. Breast, head and neck, lung and cervical cancer account for 60 per cent of India's radiotherapy needs. This underscores the need for interventions to meet the gap in machines required for equitable cancer care,'' said the study. Data from the Australian Collaboration for Cancer Outcomes Research and Evaluation (CCORE) were used by the researchers of ICMR-National Centre for Disease Informatics and Research, Bengaluru, for conducting the study. India accounts for 7 per cent of global cancer incidence, ranking third after China and the USA. By the end of 2025, the incidence of cancer in India is projected to reach 1.57 million cases, posing a significant public health challenge. Cancer burden in India As the fifth leading cause of death in the country, cancer demands urgent attention to improve prevention, diagnosis and treatment. Epidemiological data on stage, subsite and histology from the National Cancer Registry Programme were used to assess the optimal utilisation proportion for India. A sensitivity analysis was carried out. Similarly, the optimal radiotherapy fraction has also been calculated. These measures have been used to estimate the existing radiotherapy utilisation gap by comparing with the current radiotherapy utilisation from the cancer registry as well as to estimate the optimal radiotherapy machines required for the country. This study provides a comprehensive assessment of radiotherapy demand and existing gaps in radiotherapy utilisation and in the number of machines in India based on an epidemiological analysis of the cancer burden from the National Cancer Registry Programme. The study also recommended that India would require 1,585 to 2,545 machines, which may increase to a range of 2,016 to 2,291 external beam radiotherapy machines if the assumptions from previous benchmark studies are followed. This points towards an increasing demand for radiotherapy in the coming years as there is expected to be a 70-100 per cent increase in breast, head and neck and lung cancer in low and middle income countries (LMIC). Among the major indicated cancer sites, the deficit is more prominent in lymphoma and lung cancer (relative deficit of more than 70 per cent), followed by prostate, breast and oesophagus, said the study adding that radiotherapy, plays a crucial role in controlling tumour growth, reducing tumour size pre-surgery, and alleviating pain in advanced stages. Stating that high setup and operational costs are creating a significant gap between demand and resources, the study states that there is a need for greater investment to expand radiotherapy facilities to meet the growing demands of cancer patients. Urgent need to expand machines and reduce inequities The World Health Organization (WHO) recommends a minimum of one radiotherapy machine (external radiotherapy machine) per million population, with an optimal target of four per million, the study stated. For India's projected population of 1.45 billion in 2025, this translates to a need for a minimum of 1,450 machines. Yet, only 794 megavoltage (MV) machines are currently available. The shortfall is about 45 per cent from the minimal required standard, the study said. It further notes that aside from increasing the number of equipment, addressing the inequitable distribution of radiotherapy services is also crucial. To align with the country's cancer burden and ongoing control efforts, India must meet evidence-based targets for radiotherapy machine availability. The country is also ramping up efforts to develop and deploy affordable indigenous radiotherapy machines to improve access and reduce dependence on costly imports,' the study stated. The study notes that there is need for detailed situational study of radiation equipment deployment with its features and complexity, utilisation and throughput is required for informed planning and policymaking. Cancer screening and early detection programmes can facilitate the diagnosis of cancers at earlier stages. This could reduce the required quantum of radiotherapy shortly and thus, improve the overall survival of patients, the study said.
Indian Express
a day ago
- Indian Express
Knowledge Nugget: AdFalciVax and the fight against malaria — What you must-know for UPSC Exam
Take a look at the essential events, concepts, terms, quotes, or phenomena every day and brush up your knowledge. Here's your UPSC Current Affairs Knowledge Nugget for today on AdFalciVax and malaria. The Indian Council of Medical Research (ICMR) has invited the country's vaccine manufacturers to partner with it to launch and sell a malaria vaccine, AdFalciVax, that its Regional Medical Research Centre, Bhubaneshwar, has developed. In this context, let's know about this new vaccine and malaria. 1. AdFalciVax is a chimeric recombinant vaccine — a type of vaccine that uses different parts of the genes of a pathogen (in this case, Plasmodium) to create target proteins that trigger an immune response after being injected. 2. AdFalciVax uses two types of target proteins to prevent the spread of infection in two different ways. ↪ It uses the circumsporozoite protein (CSP) to prevent infection in the person who has been immunised. The CSP is produced during the sporozoite stage (when a parasite can infect a new host) and the liver stage (when a parasite enters liver cells, multiplies, and then infects red blood cells) of the parasite. 'Any immune response generated against these stages protects the immunised person from getting the infection.' Subhash Singh, project manager for development of the vaccine at the ICMR-Regional Medical Research Centre, Bhubaneswar told The Indian Express. ↪ The vaccine also uses the Pro6C protein, a fusion of parts of two different proteins — Pfs230 and Pfs48/45 — produced by Plasmodium falciparum. This protein prevents the spread of infection in the community. 3. Researchers have found that AdFalciVax provided more than 90% protection against infection in mice. The candidate vaccine has yet to undergo rigorous human trials, and the preliminary results have been obtained only through testing on animals. 4. The ICMR wants to partner with a company that can further develop its candidate vaccine, carry out human clinical trials, and scale up for commercial production. Although the ICMR will share the technology of developing AdFalciVax with the chosen company, it will continue to hold the intellectual property rights. Any intellectual property rights generated during the collaboration will be held jointly by the ICMR and the company. 5. Notably, AdFalciVax mainly targets two parts of Plasmodium falciparum, a pathogen that is the most common source of malaria in humans. In India, however, the disease is caused by Plasmodium vivax against which AdFalciVax is ineffective. To combat malaria, scientists have been working to develop a vaccine for decades but with limited success. Recently, two vaccines—RTS,S and R21—were approved for use, but their efficacy, at 75%, is quite low. That's why the announcement about ICMR's candidate vaccine has given new hope in the fight against the disease. World Malaria Day is observed every year on 25th April by the World Health Organisation to raise awareness and drive action against malaria. The theme for World Malaria Day 2025 is 'Malaria Ends With Us: Reinvest, Reimagine, Reignite.' 1. Having claimed millions of lives, malaria has been one of the deadliest diseases in human history. Currently, the disease kills about four lakh people annually, according to World Health Organization (WHO) figures. 2. Malaria is a parasitic infection transmitted by mosquitoes, typically causing symptoms such as fever, chills, night sweats, nausea, vomiting, and diarrhoea. In some cases, it can lead to severe complications such as seizures, fluid in the lungs, organ damage, and death. 3. It is most endemic in Africa — Nigeria, Congo, Tanzania, Mozambique, Niger, and Burkina Faso together account for more than half the yearly deaths. 1. India has demonstrated significant progress in reducing malaria cases and associated mortality in the country's high-endemic states, according to the findings of the World Health Organisation's (WHO) 'World Malaria Report 2024′. 2. 'India exited the HBHI [high-burden to high-impact] group officially in 2024 due to significant progress in reducing the malaria incidence and mortality observed in its high-endemic states,' the report observed. 3.'Nationwide, the number of estimated malaria cases in India decreased from 6.4 million in 2017 (the year before the HBHI's introduction) to 2 million cases in 2023 (69 per cent decrease). Similarly, the estimated malaria deaths decreased from 11,100 to 3,500 (68 per cent decrease) during the same period,' it said. 4. The HBHI refers to a targeted WHO initiative aimed at the most acutely malaria-impacted regions of the world, including several countries in Africa. Widespread resistance of malarial parasite to drugs like chloroquine has prompted attempts to develop a malarial vaccine to combat malaria. Why is it difficult to develop an effective malaria vaccine? (UPSC CSE 2010) (a) Malaria is caused by several species of Plasmodium (b) Man does not develop immunity to malaria during natural infection (c) Vaccines can be developed only against bacteria (d) Man is only an intermediate host and not the definitive host (Sources: India registers 'significant progress' in reducing malaria cases: WHO, WHO report says India reduces malaria caseload, deaths by 69% each) Subscribe to our UPSC newsletter. Stay updated with the latest UPSC articles by joining our Telegram channel – Indian Express UPSC Hub, and follow us on Instagram and X. 🚨 Click Here to read the UPSC Essentials magazine for July 2025. Share your views and suggestions in the comment box or at
